skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine

Journal Article · · Journal of Experimental Medicine
 [1];  [1];  [1];  [1];  [1];  [2];  [2];  [3];  [1];  [1];  [1]
  1. Rockefeller University, New York, NY (United States)
  2. Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
  3. Rockefeller University, New York, NY (United States); Tulane Regional Primate Research Center, Covington, LA (United States)

The role of CD8+ T lymphocytes in controlling replication of live, attenuated simian immunodeficiency virus (SIV) was investigated as part of a vaccine study to examine the correlates of protection in the SIV/rhesus macaque model. Rhesus macaques immunized for > 2 yr with nef-deleted SIV (SIVmac239Δnef) and protected from challenge with pathogenic SIVmac251 were treated with anti-CD8 antibody (OKT8F) to deplete CD8+ T cells in vivo. The effects of CD8 depletion on viral load were measured using a novel quantitative assay based on real-time polymerase chain reaction using molecular beacons. This assay allows simultaneous detection of both the vaccine strain and the challenge virus in the same sample, enabling direct quantification of changes in each viral population. Our results show that CD8+ T cells were depleted within 1 h after administration of OKT8F, and were reduced by as much as 99% in the peripheral blood. CD8+ T cell depletion was associated with a 1–2 log increase in SIVmac239Δnef plasma viremia. Control of SIVmac239Δnef replication was temporally associated with the recovery of CD8+ T cells between days 8 and 10. The challenge virus, SIVmac251, was not detectable in either the plasma or lymph nodes after depletion of CD8+ T cells. Overall, our results indicate that CD8+ T cells play an important role in controlling replication of live, attenuated SIV in vivo.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division; National Institutes of Health (NIH); German Research Foundation (DFG); Irene Diamond Fund
Grant/Contract Number:
AC52-06NA25396; RR06555; AI43868
OSTI ID:
1625182
Journal Information:
Journal of Experimental Medicine, Vol. 191, Issue 11; ISSN 0022-1007
Publisher:
Rockefeller University PressCopyright Statement
Country of Publication:
United States
Language:
English

References (43)

The Complete Nucleotide Sequence of a Pathogenic Molecular Clone of Simian Immunodeficiency Virus journal November 1990
Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques journal November 1995
Cellular Immune Response of Rhesus Monkeys Infected with a Partially Attenuated nef Deletion Mutant of the Simian Immunodeficiency Virus journal October 1995
Macaques Infected with Live Attenuated SIVmac Are Protected against Superinfection via the Rectal Mucosa journal March 1997
Plasma SIV RNA Viral Load Determination by Real-Time Quantification of Product Generation in Reverse Transcriptase-Polymerase Chain Reaction journal January 1998
Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes and Protection Against Challenge in Rhesus Macaques Immunized with a Live Attenuated Simian Immunodeficiency Virus Vaccine journal January 2000
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene journal December 1992
Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus journal December 1996
Env-Independent Protection Induced by Live, Attenuated Simian Immunodeficiency Virus Vaccines journal October 1998
The Influence of Okt8f Treatment on Allograft Survival in Rhesus Monkeys journal January 1986
Multicolor molecular beacons for allele discrimination journal January 1998
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef journal November 1999
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm journal January 1998
Turnover of CD4 + and CD8 + T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen journal April 1998
Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus. journal August 1997
Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. journal January 1997
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes journal February 1999
Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus II. Lymphocyte Depletion Does Not Abrogate Protection journal September 1998
Protective immunity induced by live attenuated simian immunodeficiency virus journal August 1998
Protection from Pathogenic SIVmac Challenge Following Short-Term Infection with a Nef-Deficient Attenuated Virus journal May 1996
A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys journal February 1997
Molecular Beacons: Spectral Genotyping of Human Alleles journal February 1998
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques journal March 1995
Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge. journal July 1999
Dramatic Rise in Plasma Viremia after CD8 + T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques journal March 1999
Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques journal January 1998
Production and Characterization of SIV Envelope-Specific Rhesus Monoclonal Antibodies from a Macaque Asymptomatically Infected with a Live SIV Vaccine journal September 1998
Molecular Beacons: Probes that Fluoresce upon Hybridization journal March 1996
Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. journal August 1997
Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. journal January 1997
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment journal May 1992
Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection journal January 1995
Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. journal January 1993
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. journal January 1994
Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. journal January 1994
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. journal January 1994
Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. journal January 1995
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. journal January 1996
Inhibition of Simian Immunodeficiency Virus (SIV) Replication by CD8+ T Lymphocytes from Macaques Immunized with Live Attenuated SIV journal August 1998
Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine journal September 1998
Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1 journal January 1999
Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge journal October 1999
Limited Protection from a Pathogenic Chimeric Simian-Human Immunodeficiency Virus Challenge following Immunization with Attenuated Simian Immunodeficiency Virus journal February 1999

Cited By (28)

Live Attenuated Rev-Independent Nef¯SIV Enhances Acquisition of Heterologous SIVsmE660 in Acutely Vaccinated Rhesus Macaques journal September 2013
Identification of Seventeen New Simian Immunodeficiency Virus-Derived CD8 + T Cell Epitopes Restricted by the High Frequency Molecule, Mamu-A*02, and Potential Escape from CTL Recognition journal October 2004
Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes journal February 2018
The role of the cytotoxic T–lymphocyte response and virus cytopathogenicity in the virus decline during antiviral therapy journal July 2003
CD8 + Cell Depletion Accelerates HIV-1 Immunopathology in Humanized Mice journal May 2010
Mechanisms of CD8 + T cell-mediated suppression of HIV/SIV replication journal March 2018
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection journal November 2008
HIV Vaccination: A Roadmap among Advancements and Concerns journal April 2018
The role of MHC class I allele Mamu-A*07 during SIVmac239 infection journal July 2011
The dynamics of simian immunodeficiency virus after depletion of CD8+ cells journal August 2018
Therapeutic vaccines against HIV infection journal May 2012
Simian Immunodeficiency Viruses with Defective nef Genes Show Increased Susceptibility to the Noncytotoxic Antiviral Activity of CD8+ Lymphocytes journal March 2002
Immunization of Macaques with Live Simian Human Immunodeficiency Virus (SHIV) Vaccines Conferred Protection Against AIDS Induced by Homologous and Heterologous SHIVs and Simian Immunodeficiency Virus journal September 2002
Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection journal December 2004
Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques journal December 2005
Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: Role of SIV-specific CD8+ T cell responses journal September 2006
TIMs: central regulators of immune responses journal November 2008
Understanding the Failure of CD8 + T-Cell Vaccination against Simian/Human Immunodeficiency Virus journal July 2007
Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques journal December 2006
Experimental depletion of CD8+ cells in acutely SIVagm-Infected African Green Monkeys results in increased viral replication journal January 2010
Vaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4+CCR5+ T cells journal February 2011
Recognition of HIV-1 Peptides by Host CTL Is Related to HIV-1 Similarity to Human Proteins journal September 2007
Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8+ T Cells Conveys the Ability to Suppress SIV Replication journal August 2011
Ex Vivo SIV-Specific CD8 T Cell Responses in Heterozygous Animals Are Primarily Directed against Peptides Presented by a Single MHC Haplotype journal August 2012
Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVΔnef live attenuated vaccine journal March 2017
Characterization of CD8+ T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling journal March 2015
Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies journal April 2018
Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus journal May 2014